HospitalInspections.org

Bringing transparency to federal inspections

1910 SOUTH AVE

LA CROSSE, WI 54601

RN SUPERVISION OF NURSING CARE

Tag No.: A0395

32670


Based on record review and interview, the facility failed to ensure patients receive effective pain management in 7 of 10 (# 1, 2, 4, 6, 7, 8, and 10) patients receiving pain management. This deficiency has the potential to affect all patients experiencing pain who are treated at this facility.

Findings include:

Review on 7/22/2014 at 10:00 AM, of facility policy titled Pain Management # Nsg 4000 dated 1/2/07, it states under Ongoing Pain Assessment/Reassessment, "Ongoing Pain assessment/reassessment ...2. Must occur prior to next intervention" and "8. Reassessment... as recommended in the Acute and Chronic Clinical Practice: Intravenous Medications - 30 minutes: Intramuscular medication - 60 minutes: Oral Medications - 60 minutes."

Per interview on 7/21/14 at 1:40 PM with Quality Improvement Nurse K, Nurse K stated that the expectation is for pain assessments to occur at the time of administration of pain medication followed by a pain reassessment in 30 minutes for intravenous medications and 60 minutes for oral medications.

Per interview with Nurse Educator G on 7/22/14 at 12:20 PM, Nurse Educator G stated pain assessment and pain medication reassessment per policy is a concern at this hospital. Nurse Educator G acknowledged that staff are not completing the required re-assessment after pain medications are given.

Review of Pt #1's MR on 7/21/14 at 2:00 PM accompanied by Quality Improvement Nurse K, revealed Pt #1 received Loritab (oral pain mediation) on 4/4/14 at 12:43 PM and 7:31 PM. There is no documentation of pain reassessment within 60 minutes of administration.

Review of Pt #2's MR on 7/21/14 at 3:00 PM accompanied by Quality Improvement Nurse K, revealed Pt #2 received Oyxcodone (oral pain medication) on 6/29/14 at 12:39 PM and on 6/30/14 at 7:24 AM. There is no documentation of pain reassessment within 60 minutes of administration. Pt #2 also received Loritab on 6/29/14 at 10:39 PM and there is no documentation of pain assessment at the time of administration or within 60 minutes of administration.

Review of Pt #4's MR on 7/21/14 at 3:30 PM accompanied by Quality Improvement Nurse K, revealed Pt #4 received Tylenol (oral pain mediation) on 6/29/14 at 4:33 AM. There is no documentation of pain reassessment within 60 minutes of administration.

Review of Pt #6's MR on 7/21/14 at 2:15 PM accompanied by Quality Improvement Nurse L, revealed Pt. #6 received Dilaudid (oral pain medication) on 5/6/14 at 11:30 AM. There is no documentation of pain reassessment within 60 minutes of administration. Pt. #6 also received Oxycodone (oral pain medication) on 5/6/14 at 1:52 AM, 6:17 AM, 11:40 AM, 3:04 PM. On 5/7/14 at 6:12 PM received the same medication. On 5/8/14 at 7:56 AM and 1:01 PM pt. # 6 received the same pain medication. On 5/9/14 at 5:58 AM, 11:36 AM, 3:31 PM and 7:29 PM received the same pain medication. There is no documentation of pain reassessment within 60 minutes of administration.

Review of Pt. #7's MR on 7/21/14 at 4:00 PM accompanied by Quality Improvement Nurse L, revealed Pt. #7 received Dilaudid (oral pain medication) on 6/24/14 at 3:43 PM and 10:57 PM. On 6/25/14 received the same medication at 5:08 AM and 12:44 PM. There is no documentation of pain reassessment within 60 minutes of administration.

Review of Pt #8's MR on 7/22/14 at 8:30 AM accompanied by Quality Improvement Nurse K, revealed Pt #8 received Toradol (intravenous pain medication) on 6/20/14 at 3:59 AM, 1:29 PM, and 10:16 PM. There is no documentation of pain reassessment within 60 minutes of administration. Pt #8 also received Toradol at 7:01 PM on 6/19/14 and there is no documentation of pain assessment at the time of administration or within 30 minutes of administration. Pt #8 received Loritab (on oral pain medication) on 6/21/14 at 12:17 AM and 12:31 PM. There is no documentation of pain reassessment within 60 minutes of administration.

Review of Pt #10's MR on 7/22/14 at 9:00 AM accompanied by Quality Improvement Nurse K, revealed Pt #10 received Fentanyl (intravenous pain medication) on 5/2/14 at 12:19 AM. There is no documentation of pain assessment at the time of administration or within 30 minutes of administration. Pt # 10 also received Loritab (oral pain medication on 5/3/14 at 7:50 PM, and on 5/4/14 at 3:58 PM and 9:35 PM and there is no documentation of pain assessment at the time of administration or within 60 minutes of administration.

CONTENT OF RECORD: INFORMED CONSENT

Tag No.: A0466

32670


Based on record review and interview, the facility failed to ensure consents are signed, dated and timed prior to the procedure in 2 of 6 (#1, 8) records containing informed consents out of a total universe of 10 records reviewed. This deficient practice has the potential to affect all patients consenting to a procedure.

Findings include:

Review on 7/22/14 at 9:45 AM of facility policy titled "Informed Consent #GL-6039", undated, it states under Signing and Witnessing Permission Forms "A witness attesting to the genuineness of the patient or patient representative's signature should sign and date the form."

During review of Pt #1's MR on 7/21/14 at 2:00 PM, noted a consent for a transrectal ultrasound and prostate biopsy (insertion of a needle through probe in the rectum to remove prostate tissue for testing) signed by Pt #1 and MA N on 3/31/14 but did not include the time the consent was signed by the patient or witness.

During review of Pt #8's MR on 7/22/14 at 8:30 AM, noted a consent for left external fixation femur and tibia (placement of metal pins into the broken thigh bone and larger bone in the lower leg) signed by Pt #8 on 6/19/14 and witnessed by RN O but did not include the time the consent was signed by the patient or witness.

During interview on 7/22/14 at 8:45 AM, Clinical Manager M stated the expectation is that staff document the time they witness the patient sign the consent prior to any procedure.

During interview on 7/21/14 at 3:30 PM, while discussing Pt #1's consent and Pt #8's consent for a prostate biopsy Continuous Readiness Director A stated "they should be timed."